Airdoc - Public Comps and Valuation Multiples

Airdoc Overview

About Airdoc

Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses, and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective, and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices, and other services. Geographically, the company generates the majority of its revenue from Mainland China.

Founded

2015

HQ

Employees

282

Website

airdoc.com

Sectors

Medical Imaging & Diagnostics
Health Data & Analytics
Vertical AI Applications
Healthcare Software
B2B SaaS
Vertical SaaS
DeepTech
HealthTech

Financials

Last FY Revenue $20.1M

Last FY EBITDA -$31.0M

EV

$82.3M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Airdoc Financials

See Airdoc valuation multiples based on analyst estimates

Airdoc P&L

In the most recent fiscal year, Airdoc reported revenue of $20.1M and EBITDA of -$31.0M.

Airdoc expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Airdoc valuation multiples based on analyst estimates

	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	XXX	$20.1M	XXX	XXX	XXX
Gross Profit	XXX	$11.1M	XXX	XXX	XXX
Gross Margin	XXX	55%	XXX	XXX	XXX
EBITDA	XXX	-$31.0M	XXX	XXX	XXX
EBITDA Margin	XXX	-155%	XXX	XXX	XXX
EBIT	XXX	-$25.5M	XXX	XXX	XXX
EBIT Margin	XXX	-127%	XXX	XXX	XXX
Net Profit	XXX	-$32.8M	XXX	XXX	XXX
Net Margin	XXX	-163%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Airdoc including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Airdoc achieved $20.1M in revenue and -$31.0M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	Analyst estimates available to subscribers	$20.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$11.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	55.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	-$31.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	-154.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	-$25.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	-127.1% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	-$32.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	-163.4% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Airdoc

This financial data table provides comprehensive performance metrics for Airdoc, a company based in Hong Kong. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Airdoc reported $20.1M in total revenue.
Fiscal year EBITDA was -$31.0M.
The company maintained a gross profit margin of 55.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was -154.6%.
Net profit margin reached -163.4% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Airdoc. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Airdoc Stock Performance

Airdoc has current market cap of HKD 1.3B (or $169M), and EV of HKD 640M (or $82.3M).

Market Cap Evolution

Airdoc Stock Data

As of January 16, 2026, Airdoc's stock price is HKD 13 (or $2).

See Airdoc trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$82.3M	$169M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Airdoc Valuation Multiples

Airdoc's trades at 4.1x EV/Revenue multiple, and -2.6x EV/EBITDA.

See valuation multiples for Airdoc and 15K+ public comps

Airdoc Financial Valuation Multiples

As of January 16, 2026, Airdoc has market cap of $169M and EV of $82.3M.

Equity research analysts estimate Airdoc's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Airdoc's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$169M	XXX	$169M	XXX	XXX	XXX
EV (current)	$82.3M	XXX	$82.3M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	4.1x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	-2.6x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-3.2x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	-5.2x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-3.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Airdoc Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Airdoc Margins & Growth Rates

Airdoc's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Airdoc's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Airdoc's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Airdoc and other 15K+ public comps

Airdoc Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	48%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	65%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	182%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial